Treatment-free survival with first-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: a critical analysis beyond PD-L1 expression

Publication Date

2026

Content Type

article

PubMed ID:

41660471

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS